SCHEMBL4032027

SCHEMBL4032027

Fc1cc[c]cc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4035082 0.79
SCHEMBL57893 0.75
SCHEMBL28968854 0.72
SCHEMBL27563466 0.72
SCHEMBL694289 0.70
SCHEMBL19921 0.68
SCHEMBL161520 0.68
SCHEMBL3395205 0.68
SCHEMBL690348 0.68
SCHEMBL423990 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242945-B2 Substituted 2-benzylidene-2H-benzo[b][1,4]thiazin-3(4H)-ones, derivatives thereof, and therapeutic uses thereof Temple University—Of the Commonwealth System of Higher Education (US) 2016-01-26 US claimed
CN-103228643-B As the benzoxazole derivative of histamine h 4 receptor part BIOPROJET (FR) 2015-11-25 CN claimed
CN-102548970-B Novel (6-oxo-1, 6-dihydropyrimidin-2-yl) amide derivatives, process for their preparation and their medical use as akt (pkb) phosphorylation inhibitors SAI NUOFEI (FR) 2015-11-25 CN claimed
US-20140086941-A1 SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2014-03-27 US claimed
WO-2012166586-A1 SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-12-06 WO claimed
EP-1513530-A4 TETRAHYDROQUINOLINES FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX INTREXON CORP (US) 2009-04-01 EP claimed
US-20050228016-A1 TETRAHYDROQUINOLINES FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX MICHELOTTI ENRIQUE 2005-10-13 US claimed
EP-1513530-A1 TETRAHYDROQUINOLINES FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX RheoGene, Inc. (US) 2005-03-16 EP claimed
EP-1474411-A2 IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES Abbott Laboratories (US) 2004-11-10 EP claimed
WO-2003105849-A1 TETRAHYDROQUINOLINES FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX RHEOGENE, INC. (US) 2003-12-24 WO claimed
WO-2003068765-A2 IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES ABBOTT LABORATORIES (US) 2003-08-21 WO claimed
US-20030153773-A1 Process for the production of dihydropyridines ABBOTT LABORATORIES 2003-08-14 US claimed
EP-2948188-B1 NEURONAL IMAGING AND TREATMENT TYLERTON INT HOLDINGS INC (VG) 2021-09-08 EP disclosed
CN-110520413-A Big ring broad-spectrum antibiotic RQX PHARMACEUTICALS INC 2019-11-29 CN disclosed
CN-110267959-A Imidazo [1,5-A ] pyrazine derivatives as PI3K delta inhibitors 百济神州有限公司 2019-09-20 CN disclosed
CN-110072842-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 美国陶氏益农公司 2019-07-30 CN disclosed
EP-1474411-A2 IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES Abbott Laboratories (US) 2004-11-10 EP disclosed
WO-2003105849-A1 TETRAHYDROQUINOLINES FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX RHEOGENE, INC. (US) 2003-12-24 WO disclosed
WO-2003068765-A2 IMPROVED PROCESS FOR THE PRODUCTION OF DIHYDROPYRIDINES ABBOTT LABORATORIES (US) 2003-08-21 WO disclosed
US-20030153773-A1 Process for the production of dihydropyridines ABBOTT LABORATORIES 2003-08-14 US disclosed